logo

For the Inventor, By the Inventor

San Francisco, CA, United States of America

Frank McCormick

This inventor holds 6 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: University of California, Leidos Biomedical Research, Inc.. Active years: 2004-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank McCormick. Retrieved from https://idiyas.com/inventor/frank-mccormick

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 66.7

 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:

goldMedal6 out of 16,025 
 
University of California
 patents
silverMedal3 out of 4 
 
Leidos Biomedical Research, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2004-2023

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents
1. 11541044 - K-Ras modulators (2023-01-03),
2. 11358940 - K-Ras modulators (2022-06-14),
3. 10857140 - K-Ras modulators (2020-12-08),
4. 10201516 - Targeting K-Ras-mediated signaling pathways and malignancy by prostratin (2019-02-12),
5. 7358086 - Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products (2008-04-15),
6. 6787321 - Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products (2004-09-07),

Title: Frank McCormick: Innovator in Cancer Research

Introduction

Frank McCormick is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of cancer research, particularly through his work on K-Ras modulators. With a total of 6 patents to his name, McCormick's innovations are paving the way for new treatments in oncology.

Latest Patents

Among his latest patents, McCormick has developed methods and compounds for inhibiting K-Ras, which are crucial for treating cancer. His patents include formulations that provide K-Ras inhibitors, along with compositions designed for effective cancer treatment. These advancements highlight his commitment to addressing critical health challenges.

Career Highlights

Throughout his career, McCormick has worked with esteemed institutions such as the University of California and Leidos Biomedical Research, Inc. His work in these organizations has allowed him to focus on groundbreaking research that has the potential to change the landscape of cancer therapy.

Collaborations

Some of his notable coworkers include Adam Renslo and David Turner. Their collaborative efforts have contributed to the success of McCormick's research initiatives.

Conclusion

Frank McCormick's innovative work in cancer research, particularly with K-Ras modulators, showcases his dedication to improving treatment options for patients. His contributions are vital in the ongoing fight against cancer, and his patents reflect a promising future in medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…